Diabetic autonomic neuropathy

Diabetes Care

Volumn 26, Issue 5, 2003, Pages 1553-1579

  Vinik, Aaron I ^a   Maser, Raelene E ^b   Mitchell, Braxton D ^c   Freeman, Roy ^d  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMIC NEUROPATHY; BLADDER DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONSTIPATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIAGNOSTIC TEST; DIARRHEA; DISEASE ASSOCIATION; DRY SKIN; ENTEROPATHY; ERECTILE DYSFUNCTION; EXERCISE TOLERANCE; FECES INCONTINENCE; HEART FUNCTION; HUMAN; ORTHOSTATIC HYPOTENSION; PATHOGENESIS; PREVALENCE; PYELONEPHRITIS; REVIEW; SEXUAL DYSFUNCTION; STOMACH EMPTYING; STOMACH PARESIS; SWEATING; TACHYCARDIA; URINARY TRACT INFECTION; UROGENITAL TRACT DISEASE; VALSALVA MANEUVER; WEIGHT REDUCTION;

AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR DISEASES; DIABETIC NEUROPATHIES; HUMANS; PREVALENCE;

EID: 0042405193     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.5.1553     Document Type: Review

References (193)

1. Vinik AI, Erbas T: Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 68:928-944, 2001
2. Freeman R: The peripheral nervous system and diabetes, In Joslin's Diabetes Mellitus. Weir G, Kahn R, King GL, Eds. Philadelphia, Lippincott, 2002
3. American Diabetes Association and American Academy of Neurology: Report and recommendations of the San Antonio Conference on diabetic neuropathy (Consensus Statement). Diabetes 37:1000-1004, 1988
4. Ziegler D: Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Reviews 7:300-315, 1999
5. Pfeifer MA, Weinberg CR, Cook DL, Reenan A, Halter JB, Ensinck JW, Porte D Jr: Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 7:447-453, 1984
6. Ewing DJ: Cardiovascular reflexes and autonomic neuropathy. Clin Sci Mol Med 55:321-327, 1978
7. Clarke BF, Ewing DJ, Campbell IW: Diabetic autonomic neuropathy. Diabetologia 17:195-212, 1979
8. Vinik AI: Diagnosis and management of diabetic neuropathy. Clin Geriatr Med 15:293-320, 1999
9. Greene DA, Lattimer SA: Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 72:1058-1063, 1983
10. Greene DA, Lattimer SA, Sima AA: Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy? Diabetes 37:688-693, 1988
11. Veves A, King GL: Can VEGF reverse diabetic neuropathy in human subjects? J Clin Invest 107:1215-1218, 2001
12. Cameron NE, Cotter MA: Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 46 (Suppl. 2):31S-37S, 1997
13. Low PA, Nickander KK, Tritschler HJ: The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46 (Suppl. 2):S38-S42, 1997
14. Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Riggs JE, Warehime SS, Christie I, Ganser G, Van Dyke K: Nitrosative stress, uric acid, and peripheral nerve function in early type 1 diabetes. Diabetes 51:2817-2825, 2002
15. Vinik AI, Erbas T, Tae S, Stansberry K, Scanelli JA, Pittenger GL: Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care 24:1468-1475, 2001
16. Pittenger GL, Malik RA, Burcus N, Boulton AJ, Vinik AI: Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes. Diabetes Care 22:1839-1844, 1999
17. Vinik AI, Pittenger GL, Milicevic Z, Knezevic-Cuca J: Autoimmune mechanisms in the pathogenesis of diabetic neuropathy. In Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity. Eisenbarth G, Ed. Austin, TX, R.G. Landes, 1999, p. 217-251
18. Sundkvist G, Lind P, Bergstrom B, Lilja B, Rabinowe SL: Autonomic nerve antibodies and autonomic nerve function in type 1 and type 2 diabetic patients. J Intern Med 229:505-510, 1991
19. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA: Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 634:7-12, 1994
20. Horrobin DF: Essential fatty acids in the management of impaired nerve function in diabetes. Diabetes 46 (Suppl. 2):S90-S93, 1997
21. Brownlee M: Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15:1835-1843, 1992
22. Obrosova IG: How does glucose generate oxidative stress in peripheral nerve? Intern Review Neurobiology 50:3-35, 2002
23. Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabo E, Szabo C: The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51:514-521, 2002
24. Ziegler D, Gries FA, Spuler M, Lessmann F, Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group: The epidemiology of diabetic neuropathy. J Diabetes Complications 6:49-57, 1992
25. Kennedy WR, Navarro X, Sutherland DER: Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology 45:773-780, 1995
26. Sharpey-Schafer EP, Taylor PJ: Absent circulatory reflexes in diabetic neuritis. Lancet 1:559-562, 1960
27. Ewing DJ, Irving JB, Kerr F, et al: Cardiovascular responses to sustained handgrip in normal subjects and in patients with diabetes mellitus: a test of autonomic function. Clin Sci Mol Med 46:295-306, 1974
28. Morley JE, Asvat MS, Klein C, Lowenthal MN: Autonomic neuropathy in black diabetic patients. S Afr Med J 52:115-116, 1977
29. Hilsted J, Jensen SB: A simple test for autonomic neuropathy in juvenile diabetics. Acta Med Scand 205:385-387, 1979
30. Mackay JD, Page MM, Cambridge J, Watkins PJ: Diabetic autonomic neuropathy: the diagnostic value of heart rate monitoring. Diabetologia 18:471-478, 1980
31. Ewing DJ, Campbell IW, Clarke BF: The natural history of diabetic autonomic neuropathy. Q J Med 49:95-108, 1980
32. Ewing DJ, Campbell IW, Clark BF: Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med 92:308-311, 1980
33. Hulper B, Willms B: Investigations of autonomic diabetic neuropathy of the cardiovascular system. Horm Metab Res Suppl 9:77-80, 1980
34. Dyrberg T, Benn J, Christiansen JS, Hilsted J, Nerup J: Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia 20:190-194, 1981
35. Xueli Z, Baidi Z, Guoxian H, Xixing Z, et al.: Peripheral and autonomic nerve function tests in early diagnosis of diabetic neuropathy. Chinese Med J 94:495-502, 1981
36. O'Brien IA, McFadden JP, Corrall RJ: The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med 79:495-502, 1991
37. DCCT Research Group: The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 41:416-423, 1998
38. Neil HA, Thompson AV, John S, et al.: Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population. Diabet Med 6:20-24, 1989
39. O'Brien IA, O'Hare JP, Lewin IG, Corrall RJ: The prevalence of autonomic neuropathy in insulin-dependent diabetes: a controlled study based on heart rate variability. Q J Med 61:957-967, 1986
40. Verrotti A, Chiarelli F, Blasetti A, Morgese G: Autonomic neuropathy in diabetic children. J Paediatr Child Health 31:545-548, 1995
41. Ewing DJ: Cardiac autonomic neuropathy. In Diabetes and Heart Disease. Jarret RJ, Ed. Amsterdam, the Netherlands, Elsevier, 1984, p. 99-132
42. Maser RE, Lenhard MJ, DeCherney GS: Cardiovascular autonomic neuropathy: the clinical significance of its determination. Endocrinologist 10:27-33, 2000
43. Schumer MP, Joyner SA, Pfeifer MA: Cardiovascular autonomic neuropathy testing in patients with diabetes. Diabetes Spectrum 11:227-231, 1998
44. Ziegler D: Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev 10:339-383, 1994
45. Vinik AI, Erbas T: Neuropathy. In Handbook of Exercise in Diabetes. Ruderman N, Devlin JT, Schneider SH, Kriska A, Eds. Alexandria, VA, American Diabetes Association, p. 463-496, 2002
46. Kahn J, Zola B, Juni J, Vinik AI: Decreased exercise heart rate in diabetic subjects with cardiac autonomic neuropathy. Diabetes Care 9:389-394, 1986
47. Roy TM, Peterson HR, Snider HL, Cyrus J, et al.: Autonomic influence on cardiovascular performance in diabetic subjects. Am J Med 87:382-388, 1989
48. Burgos LG, Ebert TJ, Asiddao C, Turner LA, et al.: Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology 70:591-597, 1989
49. Kitamura A, Hoshino T, Kon T, et al.: Patients with diabetic neuropathy are at risk of a greater intraoperative reduction in core temperature. Anesthesiology 92:1311-1318, 2000
50. Sobotka PA, Liss HP, Vinik AI: Impaired hypoxic ventilatory drive in diabetic patients with autonomic neuropathy. J Clin Endocrinol Metab 62:658-663, 1986
51. Position paper: Orthostatic hypotension, multiple system atrophy (the Shy Drager syndrome) and pure autonomic failure. J Auton Nerv Syst 58:123-124, 1996
52. Low PA, Walsh JC, Huang CY, McLeod JG: The sympathetic nervous system in diabetic neuropathy: a clinical and pathological study. Brain 98:341-356, 1975
53. Hilsted J, Parving HH, Christensen NJ, Benn J, Galbo H: Hemodynamics in diabetic orthostatic hypotension. J Clin Invest 68:1427-1434, 1981
54. Hilsted J, Galbo H, Christensen NJ: Impaired cardiovascular responses to graded exercise in diabetic autonomic neuropathy. Diabetes 28:313-319, 1979
55. Cryer PE, Silverberg AB, Santiago JV, Shah SD: Plasma catecholamines in diabetes: the syndromes of hypoadrenergic and hyperadrenergic postural hypotension. Am J Med 64:407-416, 1978
56. Tohmeh JF, Shah SD, Cryer PE: The pathogenesis of hyperadrenergic postural hypotension in diabetic patients. Am J Med 67:772-778, 1979
57. Page MM, Watkins PJ: Provocation of postural hypotension by insulin in diabetic autonomic neuropathy. Diabetes 25:90-95, 1976
58. Mathias CJ, da Costa DF, Fosbraey P, Christensen NJ, Bannister R: Hypotensive and sedative effects of insulin in autonomic failure. Br Med J (Clin Res Ed) 295:161-163, 1987
59. Winocour PH, Dhar H, Anderson DC: The relationship between autonomic neuropathy and urinary sodium and albumin excretion in insulin-treated diabetics. Diabet Med 3:436-440, 1986
60. Freeman R: Cardiovascular autonomic neuropathy. In Diabetic Neuropathy. 2nd ed. Dyck PJ, Thomas PK, Eds. Philadelphia, WB Saunders, 1999, p. 541-554
61. Vinik AI: Diabetic neuropathy: pathogenesis and therapy. Am J Med 107:17S-26S, 1999
62. Freeman R: Diabetic autonomic neuropathy: an overview. In Clinical Management of Diabetic Neuropathy. Veves A, Ed. Totowa, NJ, Humana Press, 1998, p. 181-208
63. Niakan E, Harati Y, Rolak LA, Comstock JP, Rokey R: Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy. Arch Intern Med 146:2229-2230, 1986
64. Hume L, Oakley GD, Boulton AJ, Hardisty C, Ward JD: Asymptomatic myocardial ischemia in diabetes and its relationship to diabetic neuropathy: an exercise electrocardiography study in middle-aged diabetic men. Diabetes Care 9:384-388, 1986
65. Murray DP, O'Brien T, Mulrooney R, O'Sullivan DJ: Autonomic dysfunction and silent myocardial ischaemia on exercise testing in diabetes mellitus. Diabet Med 7:580-584, 1990
66. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW: Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 67:1073-1078, 1991
67. O'Sullivan JJ, Conroy RM, MacDonald K, McKenna TJ, Mauerer BJ: Silent ischemia in diabetic men with autonomic neuropathy. Br Heart J 66:313-315, 1991
68. Koistinen MJ, Airaksinen KE, Huikuri HV, Pirttiaho H, Linnaluoto MK, Ikaheimo MJ, Takkunen JT: Asymptomatic coronary artery disease in diabetes: associated with autonomic neuropathy? Acta Diabetol 28:199-202, 1992
69. Hartmann A, Schlottog B, Jungmann E, Bohm BO, Usadel KH, Kaltenbach M: Somatic pain threshold and reactive hyperemia in autonomic diabetic neuropathy and silent myocardial ischemia. Int J Cardiol 42:121-127, 1993
70. Jermendy G, Davidovits Z, Khoor S: Silent coronary artery disease in diabetic patients with cardiac autonomic neuropathy. Diabetes Care 17:1231-1232, 1994
71. Zarich S, Waxman S, Freeman RT, Mittleman M, Hegarty P, Nesto RW: Effect of autonomic nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus. J Am Coll Cardiol 24:956-962, 1994
72. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group: Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Am J Cardiol 79:134-139, 1997
73. Jalal S, Alai MS, Khan KA, Jan VM, Rather HA, Iqbal K, Tramboo NA, Lone NA, Dar MA, Hayat A, Abbas SM: Silent myocardial ischemia and cardiac autonomic neuropathy in diabetics. J Assoc Physicians India 47:767-769, 1999
74. Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, Paycha F, Leutenegger M, Attali JR: Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 24:339-343, 2001
75. Ambepityia G, Kopelman PG, Ingram D, Swash M, Mills PG, Timmis AD: Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. J Am Coll Cardiol 15:72-77, 1990
76. Marchant B, Umachandran V, Stevenson R, Kopelman PG, Timmis AD: Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol 22:1433-1437, 1993
77. Hikita H, Kurita A, Takase B, Nagayoshi H, Uehata A, Nishioka T, Mitani H, Mizuno K, Nakamura H: Usefulness of plasma beta-endorphin level, pain threshold and autonomic function in assessing silent myocardial ischemia in patients with and without diabetes mellitus. Am J Cardiol 72:140-143, 1993
78. Langer A, Freeman MR, Josse RG, Armstrong PW: Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 25:610-618, 1995
79. Airaksinen KEJ, Koistinen MJ: Association between silent coronary artery disease, diabetes, and autonomic neuropathy. Diabetes Care 15:288-292, 1992
80. Airaksinen KE, Ikaheimo MJ, Linnaluoto MK, Niemela M, Takkunen JT: Impaired vagal heart rate control in coronary artery disease. Br Heart J 58:592-597, 1987
81. Campbell IW, Ewing DJ, Clarke BF: Painful myocardial infarction in severe diabetic autonomic neuropathy. Acta Diabetol Lat 15:210-214, 1978
82. Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ: Progression of diabetic autonomic neuropathy over a decade of insulin-dependent diabetics. Q J Med 75:635-646, 1990
83. Ewing DJ, Boland O, Neilson JM, Cho CG, Clarke BF: Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia 34:182-185, 1991
84. Jermendy G, Toth L, Voros P, Koltai MZ, Pogatsa G: Cardiac autonomic neuropathy and QT interval length: a follow-up study in diabetic patients. Acta Cardiol 46:189-200, 1991
85. Rathmann W, Ziegler D, Jahnke M, et al.: Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 10:820-824, 1993
86. Hathaway DK, El-Gebely S, Cardoso SS, Elmer DS, Gaber AO: Autonomic control dysfunction in diabetic transplant recipients succumbing to sudden cardiac death. Transplantation 59:634-637, 1995
87. Orchard TJ, Lloyd CE, Maser RE, Kuller LH: Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract 34 (Suppl.): S165-S171, 1996
88. Sawicki PT, Bender DR, Berger M: Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia 39:77-81, 1996
89. Navarro X, Kennedy WR, Aeppli D, Sutherland DE: Neuropathy and mortality in diabetes: influence of pancreas transplantation. Muscle Nerve 19:1009-1016, 1996
90. Toyry JP, Niskanen LK, Mantysaari MJ, Lansimies EA, Uusitupa MIJ: Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM: ten-year follow-up from the diagnosis. Diabetes 45:308-315, 1996
91. Sawicki PT, Kiwitt S, Bender R, Berger M: The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J Intern Med 243:49-56, 1998
92. Veglio M, Sivieri R, Chinaglia A, Scaglione L, Cavallo-Perin P: QT interval prolongation and mortality in type 1 diabetic patients: a 5-year cohort prospective study: Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate Diabetes Care 23:1381-1383, 2000
93. Gerritsen J, Dekker JM, ten Voorde BJ, Kostense PJ, Heine RJ, Bouter LM, Heethaar RM, Stehouwer CD: Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24:1793-1798, 2001
94. Chen HS, Hwu CM, Kuo BI, Chiang SC, Kwok CF, Lee SH, Lee YS, Weih MJ, Hsiao LC, Lin SH, Ho LT: Abnormal cardiovascular reflex tests are predictors of mortality in type 2 diabetes mellitus. Diabet Med 18:268-273, 2001
95. Maser RE, Mitchell BD, Vinik AI, Freeman R: The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. Diabetes Care. In press
96. Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8:491-498, 1985
97. Page MM, Watkins PJ: Cardiorespiratory arrest and diabetic autonomic neuropathy. Lancet 1:14-16, 1978
98. Maser RE, Pfeifer MA, Dorman JS, Kuller LH, Becker DJ, Orchard TJ: Diabetic autonomic neuropathy and cardiovascular risk: Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med 150:1218-1222, 1990
99. Spallone V, Maiello MR, Cicconetti E, Menzinger G: Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes. Diabetes Res Clin Pract 34 (Suppl. 3):169-179, 1997
100. Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW: Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM). Muscle Nerve 21:72-80, 1998
101. Menzinger G, Gambardella S, Spallone V: The relationship of autonomic neuropathy to other diabetic complications. Diabet Med 10 (Suppl. 2):74S-76S, 1993
102. Sivieri R, Veglio M, Chinaglia A, et al.: Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. Diabet Med 10:920-924, 1993
103. Veglio M, Borra M, Stevens LK, Fuller JH, et al.: The relation between QTc interval prolongation and diabetic complications: the EURODIAB IDDM Complications Study Group. Diabetologia 42:68-75, 1999
104. Kahn JK, Sisson JC, Vinik AI: Prediction of sudden cardiac death in diabetic autonomic neuropathy. J Nucl Med 29:1605-1606, 1988
105. Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, Wieland DM, Pfeifer MA, Schwaiger M: Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation 98:961-968, 1998
106. Suarez GA, Kottke TE, Callahan MJ, Norell JE, O'Brien PC, Dyck PJ: Is autonomic neuropathy an important cause of sudden death in diabetes mellitus? (Abstract) Neurology 56 (Suppl. 3):A208, 2001
107. Johnson BF, Nesto R, Pfeifer M, Slater W, Vinik A, Wackers F, Young L: Systolic and diastolic dysfunction in diabetic patients with neuropathy (Abstract). Diabetes 46 (Suppl. 1):314A, 1997
108. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, Pyorala K, Tuomilehto J: Impact of diabetes on mortality after the first myocardial infarction: The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 21:69-75, 1998
109. Fava S, Azzopardi J, Muscat HA, Fennech FF: Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 16:1615-1618, 1993
110. Katz A, Liberty IF, Porath A, Ovsyshcher I, Prystowsky EN: A simple beside test of 1-minute heart rate variability during deep breathing as a prognostic index after myocardial infarction. Am Heart J 138:32-38, 1999
111. Toyry JP, Niskanen LK, Lansimies EA, Partanen KPL, Uusitupa MIJ: Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 27:1316-1318, 1996
112. Ewing DJ: Diabetic autonomic neuropathy and the heart. Diabetes Res Clin Pract 30 (Suppl.)S31-S36, 1996
113. Fraser DM, Campbell IW, Ewing DJ, Murray A, Neilson JM, Clarke BF: Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus. Diabetes 26:546-550, 1977
114. Vinik AI, Milicevic Z: Recent advances in the diagnosis and treatment of diabetic neuropathy. Endocronologist 6:443-461, 1996
115. Javorka K, Javorkova J, Petraskova M, et al.: Heart rate variability and cardiovascular tests in young patients with diabetes mellitus type 1. J Pediatr Endocrinol Metab 12:423-431, 1999
116. Young RJ, Ewing DJ, Clarke BF: Nerve function and metabolic control in teenage diabetics. Diabetes 32:142-147, 1983
117. Ewing DJ, Clarke BF: Diabetic autonomic neuropathy: a clinical viewpoint. In Diabetic Nettropathy. Dyck PJ, Thomas PK, Asbury AK, Weingrad AI, Porte D, Eds. Philadelphia, WB Saunders, 1987, p. 66-88
118. Karavanaki K, Baum JD: Prevalence of microvascular and neurologic abnormalities in a population of diabetic children. J Pediatr Endocrinol 12:411-422, 1999
119. Low PA, Fealey RD: Sudomotor neuropathy: In Diabetic Neuropathy. Dyck PJ, Thomas PK, Asbury AK, Weingrad AI, Porte D, Eds. Philadelphia, WB Saunders, 1987, p. 140-145
120. DePonti F, Fealey RD, Malagelada JR: Gastrointestinal syndromes due to diabetes mellitus. In Diabetic Neuropathy. Dyck PJ, Thomas PK, Asbury AK, Weingrad AI, Porte D, Eds. Philadelphia, WB Saunders, 1987, p. 155-161
121. Smith SA, Smith SE: Assessment of pupillary function in diabetic neuropathy. In Diabetic Neuropathy. Dyck PJ, Thomas PK, Asbury AK, Weingrad AI, Porte D, Eds. Philadelphia, WB Saunders, 1987, p. 134-139
122. Levitt NS, Stansberry KB, Wynchank S, Vinik Al: The natural progression of autonomic neuropathy and autonomic function tests in a cohort of people with IDDM. Diabetes Care 19:751-754, 1996
123. Farup CE, Leidy NK, Murray M, Williams GR, Helbers L, Quigley EMM: Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care 21:1699-1706, 1998
124. Channer KS, Jackson PC, O'Brien I, Corrall RJ, Coles DR, Davies ER, Virjee JP: Oesophageal function in diabetes mellitus and its association with autonomic neuropathy. Diabet Med 2:378-382, 1985
125. Kong MF, Horowitz M, Jones KL, Wishart JM, Harding PE: Natural history of diabetic gastroparesis. Diabetes Care 22:503-507, 1999
126. Horowitz M, Edelbroek M, Fraser R, Maddox A, Wishart J: Disordered gastric motor function in diabetes mellitus: recent insights into prevalence, pathophysiology, clinical relevance and treatment. Scand J Gastroenterol 26:673-684, 1991
127. Schiller LR, Santa Ana CA, Schmulen AC, Hendler RS, Harford WV, Fordtran JS: Pathogenesis of fecal incontinence in diabetes mellitus: evidence for internal-anal-sphincter dysfunction. N Engl J Med 307:1666-1671, 1982
128. Neumann C, Schmid H: Relationship between the degree of cardiovascular autonomic dysfunction and symptoms of neuropathy and other complications of diabetes mellitus. Braz J Med Biol Res 28:751-757, 1995
129. Blaivas JG: The neurophysiology of micturition: a clinical study of 550 patients. J Urol 127:958-963, 1982
130. Ellenberg M: Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 92:321-323, 1980
131. Bradley WE: Diagnosis of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 92:323-326, 1980
132. Beylot M, Marion D, Noel G: Ultrasonographic determination of residual urine in diabetic subjects: relationship to neuropathy and urinary tract infection. Diabetes Care 5:501-505, 1982
133. Norden G, Granerus G, Nyberg G: Diabetic cystopathy: a risk factor in diabetic nephropathy? J Diabet Complications 2:203-206, 1988
134. Frimodt-Moller C, Mortensen S: Treatment of diabetic cystopathy. Ann Intern Med 92:327-328, 1980
135. Ioanid CP, Noica N: Incidence and diagnostic aspects of the bladder disorders in diabetics. Eur Urol 7:211-214, 1981
136. McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF: The prevalence of diabetic impotence. Diabetologia 18:279-283, 1980
137. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151:54-61, 1994
138. Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB: Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 25:1458-1463, 2002
139. Vinik AI, Richardson D: Erectile dysfunction in diabetes. Diabetes Reviews 6:16-33, 1998
140. Enzlin P, Mathieu C, Vanderschueren D, Demyttenaere K: Diabetes mellitus and female sexuality: a review of 25 years' research. Diabet Med 15:809-815, 1998
141. Bosman DR, Osborne CA, Marsden JT, Macdougall IC, Gardner WN, Watkins PJ: Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure. Diabet Med 19:65-69, 2002
142. Robertson D, Krantz SB, Biaggioni I, Robertson D: The anemia of microgravity and recumbency: role of sympathetic neural control of erythropoietin production. Acta Astronautica 33:137-141, 1994
143. Ryder RE, Owens DR, Hayes TM, Ghatel MA, Bloom SR: Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. Br Med J 301:783-787, 1990
144. Hepburn DA, Patrick AW, Eadington DW, Ewing DJ, Frier BM: Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabet Med 7:711-717, 1990
145. Bottini P, Boschetti E, Pampanelli S, Ciofetta M, Del Sindaco P, Scionti L, Brunetti P, Bolli GB: Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes 46:814-823, 1997
146. Fanelli C, Pampanelli S, Lalli C, Del Sindaco P, Ciofetta M, Lepore M, Porcellati F, Bottini P, Di Vincenzo A, Brunetti P, Bolli GB: Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes 46:1172-1181, 1997
147. Meyer C, Grossmann R, Mitrakou A, Mahler R, Veneman T, Gerich J, Bretzel RG: Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients Diabetes Care 21:1960-1966, 1998
148. Cryer PE: Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious cycle. Diabetes 41:255-260, 1992
149. Dagogo-Jack SE, Craft S, Cryer PE: Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus: recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 91:819-828, 1993
150. Cryer PE: Hypoglycemia-associated autonomic failure in diabetes. Am J Physiol Endocrinol Metab 281:E1115-E1121, 2001
151. Hoeldtke RD, Boden G: Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy. Ann Intern Med 120:512-517, 1994
152. Stephenson JM, Kempler P, Perin PC, Fuller JH: Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications Study. Diabetologia 39:1372-1376, 1996
153. Low P, Lagerlund TD, McManis PG: Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int Rev Neurobiol 31:355-438, 1989
154. Stansberry KB, Hill MA, Shapiro SA, McNitt PM, Bhatt BA, Vinik AI: Impairment of peripheral blood flow responses in diabetes resembles an enhanced aging effect. Diabetes Care 20:1711-1716, 1997
155. Stansberry KB, Peppard HR, Babyak LM, Popp G, McNitt PM, Vinik AI: Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunction. Diabetes Care 22:1549-1554, 1999
156. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG: A prospective study of risk factors for diabetic foot ulcer: the Seattle Diabetic Foot Study. Diabetes Care 22:1036-1042, 1999
157. Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJM: Osteopenia, neurological dysfunction, and the development of charcot neuroarthropathy. Diabetes Care 18:34-38, 1995
158. American Diabetes Association and American Academy of Neurology: Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Diabetes Care 15:1080-1107, 1992
159. Pfeifer MA, Cook D, Brodsky J, Tice D, Reenan A, Swedine S, Halter JB, Porte D Jr: Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes 31:339-345, 1982
160. Ewing DJ, Campbell IW, Murray H, Neilson JM, Clarke BF: Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. BMJ 1:145-147, 1978
161. Borst C, Weiling W, van Brederode JFM, Hond A, DeRijk LG, Dunning AJ: Mechanisms of initial heart rate response to postural change. Am J Physiol 243: H676-H681, 1982
162. Ziegler D, Laux G, Dannehl K, Spuler M, et al.: Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med 9:166-175, 1992
163. Sandroni P, Benarroch EE, Low PA: Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure. J Appl Physiol 71:1563-1567, 1991
164. American Academy of Neurology Therapeutics and Technology Assessment Subcommittee: Assessment: clinical autonomic testing report Neurology 46:873-880, 1996
165. Pfeifer MA, Schumer MP, Gelber DA: Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes 46 (Suppl. 2):S82-S89, 1997
166. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043-1065, 1996
167. Freeman R, Saul P, Roberts M, Berger RD, Broadbridge C, Cohen R: Spectral analysis of heart rate in diabetic autonomic neuropathy. Arch Neurol 48:185-190, 1991
168. Howorka K, Pumprla J, Schabmann A: Optimal parameters for short-term heart rate spectrogram for routine evaluation of diabetic cardiovascular autonomic neuropathy. J Auton Nerv Syst 69:164-172, 1998
169. Vinik AI, Suwanwalaikorn S: Autonomic neuropathy. In Current Therapy of Diabetes Mellitus. De Fronzo RM, Ed. St. Louis, MO, Yearbook, 1997, p. 165-176
170. Vinik AI, Holland MT, Le Beau JM, Liuzzi FJ, Stansberry KB, Colen LB: Diabetic neuropathies. Diabetes Care 15:1926-1975, 1992
171. Battle WM, Snape WJ Jr, Alavi A, Cohen S, Braunstein S: Colonic dysfunction in diabetes mellitus. Gastroenterology 79:1217-1221, 1980
172. Sundkvist G: Autonomic nervous function in asymptomatic diabetic patients with signs of peripheral neuropathy. Diabetes Care 4:529-534, 1981
173. Weinberg CR, Pfeifer MA: Development of a predictive model for symptomatic neuropathy in diabetes. Diabetes 35:873-880, 1986
174. Mustonen J, Uusitipa M, Mantysaari M, et al.: Changes in autonomic nervous function during the 4-year follow-up in middle-aged diabetic and nondiabetic subjects initially free of coronary heart disease. J Intern Med 241:227-235, 1997
175. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RE, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
176. Wein TH, Albers JW: Diabetic neuropathies. Phys Med Rehabil Clin N Am 12:307-320, 2001
177. Karavanaki-Karanassiou K: Autonomic neuropathy in children and adolescents with diabetes mellitus. J Pediatr Endocrinol Metab 14 (Suppl. 5):1379-1386, 2001
178. Massin MM, Derkenne B, Tallsund M, Rocour-Brumioul D, Ernould C, Lebrethon MC, Bourguignon JP: Cardiac autonomic dysfunction in diabetic children. Diabetes Care 22:1845-1850, 1999
179. DCCT Research Group: Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes 37:476-481, 1988
180. Jaffe RS, Aoki TT, Rohatsch PL, Disbrow EA, Fung DL: Predicting cardiac autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus. Clin Auton Res 5:155-158, 1995
181. May O, Arildsen H, Damsgaard EM, Mickley H: Cardiovascular autonomic neuropathy in insulin-dependent diabetes mellitus: prevalence and estimated risk of coronary heart disease in the general population. J Intern Med 248:483-491, 2000
182. Clark CM, Vinicor F: Introduction: Risks and benefits of intensive management in non-insulin-dependent diabetes mellitus: the fifth Regenstrief conference. Ann Intern Med 124:81-85, 1996
183. Pfeifer MA, Schumer MP: Clinical trials of diabetic neuropathy: past, present, and future. Diabetes 44:1355-1361, 1995
184. Feldman EL, Stevens MJ, Greene DA: Pathogenesis of diabetic neuropathy. Clin Neurosci 4:365-370, 1997
185. Low PA, Nickander KK: Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 40:873-877, 1991
186. Ziegler D, Reljanovic M, Mehnert H, Gries FA: Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrinol Diabetes 107:421-430, 1999
187. Manzella D, Barbieri M, Ragno E, Paolisso G: Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes. Am J Clin Nutr 73:1052-1057, 2001
188. Kontopoulos AG, Athyros VG, Didangelos TP, Papageorgiou AA, Avramidis MJ, Mayroudi MC, Karamitsos DT: Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care 20:355-361, 1997
189. Malik RA, Williamson S, Abbott C, Carrington AL, Iqbal J, Schady W, et al.: Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 352:1978-1981, 1998
190. Ebbehoj E, Poulsen PL, Hansen KW, Knudsen ST, Molgaard H, Mogensen CE: Effects on heart rate variability of metoprolol supplementary to on going ACE-inhibitor treatment in type I diabetic patients with abnormal albuminuria. Diabetologia 45:965-975, 2002
191. Singleton JR, Smith AG, Bromberg MB: Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 24:1225-1228, 2001
192. Sochett E, Daneman D: Early diabetes-related complications in children and adolescents with type 1 diabetes: implications for screening and intervention. Endocrinol Metab Clin North Am 28:865-882, 1999
193. Howorka K, Pumprla J, Haber P, et al.: Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovascular Res 34:206-214, 1997